Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

BACKGROUND: The standard dose of rituximab used in rheumatoid arthritis (RA) is 1000 mg but recent studies have shown that low dose (500 mg) is also effective. Efficacy of low dose rituximab in rheumatoid arthritis (RA) refractory to first-line non-biologic Disease Modifying Anti Rheumatic Drugs (DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijesinghe, Harindu, Galappatthy, Priyadharshini, de Silva, Rajiva, Seneviratne, Suranjith L., Saravanamuttu, Ushagowry, Udagama, Preethi, Hart, Melanie, Kelleher, Peter, Senerath, Upul, Fernandopulle, Rohini, Weerasekera, Lilani P., Wijayaratne, Lalith S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518147/
https://www.ncbi.nlm.nih.gov/pubmed/28724365
http://dx.doi.org/10.1186/s12891-017-1673-3

Ejemplares similares

Ejemplares similares